期刊文献+

不同铁状态下HL-60细胞中IRP_2 mRNA的表达 被引量:1

The Expressions of IRP_2 mRNA in HL-60 Cells Under Different Iron Circumstances
下载PDF
导出
摘要 目的本研究通过加铁和去铁干预试验,了解不同铁状态下IRP2在人白血病HL-60细胞中的表达情况。方法将FeCl3或去铁胺(Desferrioxamine,DFO)加入含有体积分数10%胎牛血清的RPMI-1640培养液中,使HL-60细胞处于缺铁或富铁的不同状态下培养。于细胞培养后第12、24和48 h收集各组细胞,提取细胞总RNA。采用RT-PCR半定量法测定IRP2mRNA的相对表达量。结果各实验组之间IRP2mRNA的表达量变化不大,组间差异无统计学意义(F=1.199,P>0.05),但随细胞培养时间的延长,IRP2mRNA的表达降低,组内差异有统计学意义(F=43.418,P<0.05)。结论细胞内铁水平状态可能不影响IRP2mRNA的表达。 Objective To investigate the expression levels of IRP2mRNA under different iron circumstances of HL-60 cells. Methods HL- 60 cells were cultured in RPMI-1640 medium supplemented with 10% heat-inactivated fetal bovine serum which was treated with ferric chloride( FeCl3 ) or deferoxamine(DFO). The cells were harvested at 12,24 and 48h proliferation, and total RNA was isolated; cDNA was synthesized by reverse transcription ( RT), and relative amounts of IRP2 mRNA were determined by RT-PCR. Results The levels of IRP2 mRNA remained constant in all cells. There wasn' t significant difference among the subjects( F = 1. 199, P 〉 0.05 ). However, the expressions of IRP2 mRNA were decreased when the time of cell culture was prolonged. There was significant difference among the subjects (F = 43. 418, P 〈 0.01 ). Conclusions The levels of iron in cells might not affect the expressions of IRP2 mRNA in HL-60 cells.
出处 《肿瘤基础与临床》 2007年第4期299-300,共2页 journal of basic and clinical oncology
关键词 HL-60细胞 铁调节蛋白2 去铁胺 FECL3 HL-60 cell IRP2 mRNA DFO FeCl3
  • 相关文献

参考文献6

  • 1Henderson BR,Menotti E,Kuhn LC.Iron regulatory proteins 1 and 2 bind distinct sets of RNA target sequences[J].J Biol Chem,1996,271 (9):4900-4908.
  • 2Guo B,Brown FM,Phillips JD,et al.Characterization and expression of iron regulatory protein 2 (IRP2).Presence of multiple IRP2 transcripts regulated by intracellular iron levels[J].J Biol Chem,1995,270(28):16529-16535.
  • 3Kang DK,Jeong J,Drake SK,et al.Iron regulatory protein 2 as iron sensor.Iron-dependent oxidative modification of cysteine[J].J Biol Chem,2003,278(17):14857-14864.
  • 4Kuhn LC,Hentze MW.Coordination of cellular iron metabolism by post-transcriptional gene regulation[J].J Inorg Biochem,1992,47(3 -4):183 -195.
  • 5贾国存,刘玉峰.富铁对HL-60细胞增殖及化疗药物诱导其凋亡的影响[J].中华血液学杂志,2001,22(7):381-382. 被引量:12
  • 6刘玉峰,贾国存,曾利,伍学强,盛光耀,孙玲.铁剥夺诱导HL-60细胞凋亡及对化疗药物诱导HL-60细胞凋亡的影响[J].中华儿科杂志,2001,39(12):735-738. 被引量:9

二级参考文献5

  • 1赵卫红,叶奇鲁,于载泺.细胞凋亡与白血病治疗[J].中华儿科杂志,1996,34(2):139-141. 被引量:2
  • 2Hann HL,Stahlhut MW,Hann CL.Effect of iron and desferoxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines[].Hepatology.1990
  • 3Hann HL,Stahlhut MW,Blumberg BS.Iron nutrition and tumor growth:decreased tumor growth in iron-deficient mice[].Cancer Research.1988
  • 4Hann HL,Stahlhut MW,Menduke H.Iron enhances tumor growth[].Cancer.1991
  • 5贾苍松,罗春华,汪志凌.128例急性白血病患儿输血治疗与复发的关系[J].中华儿科杂志,1999,37(11):700-701. 被引量:13

共引文献16

同被引文献17

  • 1贾国存,高举,廖清奎,李丰益,袁粒星,何斌.白血病细胞可变铁池的检测及其意义[J].中国实验血液学杂志,2006,14(3):468-470. 被引量:2
  • 2张秋堂,王叨,刘玉峰.铁对白血病细胞HL-60线粒体膜电位及凋亡的影响[J].实用儿科临床杂志,2006,21(15):998-999. 被引量:5
  • 3汤有才,赵春,贾国存,李丰益,廖清奎,牛文忠,王军.铁剥夺对K562细胞凋亡及细胞周期的影响[J].郑州大学学报(医学版),2006,41(6):1055-1057. 被引量:2
  • 4赵春,李丰益,贾苍松,高举,廖清奎.去铁胺对K562细胞多药耐药基因MDR1及核因子κB表达的影响[J].临床儿科杂志,2007,25(1):47-50. 被引量:2
  • 5Selig RA, White L, Gramacho G, et al. Failure of iron chelators to reduce tumor growth in human neuroblastoma xenografts. Cancer Res, 1998; 58(3): 473-478.
  • 6Damell G, Richardson DR. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents III : the effect of the ligands on molecular targets involved in proliferation. Blood, 1999; 94(2) : 781 -792.
  • 7Rakba N, Loyer P, Gilot D, et al. Antiproliferative and apoptotic effects of O-Trensox, a new synthetic iron chelator, on differen- tiated human hepatoma cell lines. Carcinogenesis, 2000; 21 (5) : 943 - 951.
  • 8Gao J, Richardson DR. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents. IV: The mechanisms involved in inhibiting cell-cycle progression. Blood, 2001 ; 98(3) : 842 -850.
  • 9Lovejoy DB, Richardson DR. Novel "hybrid" iron chelators derived from aroyl-hydrazones and thiosemicarbazones demonstrate selective antipmliferative activity against tumor cells. Blood, 2002 ; 100(2) : 666 -676.
  • 10Le NT, Richardson DR. Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21CIP1/ WAF1, but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation. Carcinogenesis, 2003 ; 24 ( 6 ), 1045 - 1058.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部